Literature DB >> 20981795

Characterization of genotype G8 strains from Malawi, Kenya, and South Africa.

Nicola Page1, Mathew Esona, Mapaseka Seheri, James Nyangao, Pieter Bos, Jason Mwenda, Duncan Steele.   

Abstract

Reviews of the global distribution of rotavirus genotypes have revealed the continuous circulation of G8 strains in Africa, often responsible for more cases of rotavirus disease than the more common G1-G4 rotavirus strains. During the study, genotype G8 strains from Malawi, Kenya, and South Africa were detected and the VP7 and VP4 genes of selected specimens were sequenced. Results indicated that G8 strains appeared to reassort frequently and were associated with P[6], P[4], and P[8] specificity. Phylogenetic analysis suggested that G8 strains occurred in a North/South African phylogenetic divide. In addition, G8 strains appear to be able to infect non-human primates and strains with close phylogenetic relationships were detected in the same year on two continents. Any rotavirus vaccine introduced into African environments will need to demonstrate protective efficacy against unusual genotype combinations, new serotypes, and animal strains. Therefore, continuous monitoring of rotavirus strains in human and animal populations in Africa is a necessity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981795     DOI: 10.1002/jmv.21912

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Full-length genome analysis of the first human G8P[14] rotavirus strain from Morocco suggests evidence of zoonotic transmission.

Authors:  Sanaâ Alaoui Amine; Marouane Melloul; Moulay Abdelaziz El Alaoui; Nadia Touil; Elmostafa El Fahime
Journal:  Virus Genes       Date:  2019-06-13       Impact factor: 2.332

2.  Intra-genotypic diversity of archival G4P[8] human rotaviruses from Washington, DC.

Authors:  Sarah M McDonald; Kristin Davis; John K McAllen; David J Spiro; John T Patton
Journal:  Infect Genet Evol       Date:  2011-06-25       Impact factor: 3.342

3.  Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi.

Authors:  Toyoko Nakagomi; Osamu Nakagomi; Winifred Dove; Yen Hai Doan; Desiree Witte; Bagrey Ngwira; Stacy Todd; A Duncan Steele; Kathleen M Neuzil; Nigel A Cunliffe
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

4.  Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.

Authors:  Andrew Duncan Steele; Kathleen M Neuzil; Nigel A Cunliffe; Shabir A Madhi; Pieter Bos; Bagrey Ngwira; Desiree Witte; Stacy Todd; Cheryl Louw; Mari Kirsten; Sanet Aspinall; Leen Jan Van Doorn; Alain Bouckenooghe; Pemmaraju V Suryakiran; Htay Htay Han
Journal:  BMC Infect Dis       Date:  2012-09-13       Impact factor: 3.090

5.  Genomic constellation of human Rotavirus A strains identified in Northern Brazil: a 6-year follow-up (2010-2016).

Authors:  Marcelle Silva-Sales; Elcio Leal; Flavio Augusto de Pádua Milagres; Rafael Brustulin; Vanessa Dos Santos Morais; Roberta Marcatti; Emerson Luiz Lima Araújo; Steven S Witkin; Xutao Deng; Ester Cerdeira Sabino; Eric Delwart; Adriana Luchs; Antonio Charlys da Costa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-12-18       Impact factor: 1.846

6.  G8 rotaviruses with conserved genotype constellations detected in Malawi over 10 years (1997-2007) display frequent gene reassortment among strains co-circulating in humans.

Authors:  Toyoko Nakagomi; Yen Hai Doan; Winifred Dove; Bagrey Ngwira; Miren Iturriza-Gómara; Osamu Nakagomi; Nigel A Cunliffe
Journal:  J Gen Virol       Date:  2013-02-13       Impact factor: 3.891

7.  Identification of novel Ghanaian G8P[6] human-bovine reassortant rotavirus strain by next generation sequencing.

Authors:  Francis E Dennis; Yoshiki Fujii; Kei Haga; Susan Damanka; Belinda Lartey; Chantal A Agbemabiese; Nobuo Ohta; George E Armah; Kazuhiko Katayama
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.